Nagaoka H - Search Results

1

[Effect of intratumoral injection of the mixture of OK-432 and fibrinogen (OK/fbg) on gastric cancer].

Takeda T, Wakasugi T, Katsumoto Y, Sakita I, Nagaoka H, Morimoto H, Tsujinaka T, Monden T, Shiozaki H, Shimano T, et al. Takeda T, et al. Among authors: nagaoka h. Gan To Kagaku Ryoho. 1992 Aug;19(10 Suppl):1458-60. Gan To Kagaku Ryoho. 1992. PMID: 1530293 Japanese.

2

Use of fibrinogen to enhance the antitumor effect of OK-432. A new approach to immunotherapy for colorectal carcinoma.

Monden T, Morimoto H, Shimano T, Yagyu T, Murotani M, Nagaoka H, Kawasaki Y, Kobayashi T, Mori T. Monden T, et al. Among authors: nagaoka h. Cancer. 1992 Feb 1;69(3):636-42. doi: 10.1002/1097-0142(19920201)69:3<636::aid-cncr2820690306>3.0.co;2-w. Cancer. 1992. PMID: 1370392

3

[Intratumoral injection of OK-432 in conjunction with fibrinogen greatly enhances antitumor effect on colorectal carcinomas].

Monden T, Morimoto H, Murotani M, Yagyu T, Nagaoka H, Shimano T, Mori T. Monden T, et al. Among authors: nagaoka h. Nihon Geka Gakkai Zasshi. 1991 Jan;92(1):31-6. Nihon Geka Gakkai Zasshi. 1991. PMID: 1707498 Japanese.

4

Augmentation of antitumor immunity in regional lymph nodes by local immunotherapy.

Sakita I, Monden T, Nagaoka H, Katsumoto Y, Wakasugi T, Tomita N, Takeda T, Kobayashi T, Shimano T, Mori T. Sakita I, et al. Among authors: nagaoka h. Biotherapy. 1993;6(2):103-12. doi: 10.1007/BF01877423. Biotherapy. 1993. PMID: 8398569 Clinical Trial.

5

Augumentation of splenic antitumor immunity by local immunotherapy in gastric cancer patients.

Wakasugi T, Takeda T, Monden T, Katsumoto Y, Sakita I, Nagaoka H, Fukunaga M, Tomita N, Kobayashi T, Shiozaki H, Shimano T, Monden M. Wakasugi T, et al. Among authors: nagaoka h. Biotherapy. 1997;10(2):99-106. doi: 10.1007/BF02678536. Biotherapy. 1997. PMID: 9373731 Clinical Trial.

6

Establishment of cytotoxic CD4+ T cell clones from cancer patients treated by local immunotherapy.

Nagaoka H, Monden T, Sakita I, Katsumoto Y, Wakasugi T, Kawasaki Y, Tomita N, Takeda T, Yagyu T, Morimoto H, et al. Nagaoka H, et al. Biotherapy. 1992;5(4):241-50. doi: 10.1007/BF02179041. Biotherapy. 1992. PMID: 1363274

7

[The effect of combination chemotherapy to adapted to chronotherapy with 5-fluorouracil, leucovorin, mitomycin C and cisplatin in patients with gastric or colorectal cancer].

Kamoshita N, Yokomori T, Iesato H, Ohya T, Nagaoka H, Okabe T, Kato Y, Takeyoshi I, Ohwada S, Morishita Y. Kamoshita N, et al. Among authors: nagaoka h. Gan To Kagaku Ryoho. 2000 May;27(5):711-6. Gan To Kagaku Ryoho. 2000. PMID: 10832439 Clinical Trial. Japanese.

8

[Effect of combination chemotherapy with multiple drugs (FLMP therapy) based on the circadian rhythms of the human body in advanced recurrent gastric cancer].

Yokomori T, Iesato H, Kamoshita N, Nagaoka H, Okabe T, Kato Y. Yokomori T, et al. Among authors: nagaoka h. Gan To Kagaku Ryoho. 1999 Nov;26(13):2043-8. Gan To Kagaku Ryoho. 1999. PMID: 10584569 Clinical Trial. Japanese.

9

[Genetic testing for ret mutation for early diagnosis and treatment in familial medullary thyroid carcinoma: a case report].

Nagaoka H, Iino Y, Takei H, Maemura M, Horiguchi J, Horii Y, Matumoto H, Koibuchi Y, Ninomiya J, Yokoe T, Oyama T, Morishita Y. Nagaoka H, et al. Gan To Kagaku Ryoho. 1998 Apr;25 Suppl 3:481-5. Gan To Kagaku Ryoho. 1998. PMID: 9589057 Japanese.

10

[An autopsied case of double carcinomata consisting of hepatocellular and renal cell carcinoma associated with adrenocortical adenoma].

Nagaoka H, Nakayama I, Ishimatsu T, Terao H. Nagaoka H, et al. Gan No Rinsho. 1989 Feb;35(3):404-10. Gan No Rinsho. 1989. PMID: 2538667 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters